This is a Validated Antibody Database (VAD) review about human ATP6V1G1, based on 2 published articles (read how Labome selects the articles), using ATP6V1G1 antibody in all methods. It is aimed to help Labome visitors find the most suited ATP6V1G1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ATP6V1G1 synonym: ATP6G; ATP6G1; ATP6GL; ATP6J; Vma10; V-type proton ATPase subunit G 1; ATPase, H+ transporting, lysosomal (vacuolar proton pump), member J; ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1; V-ATPase 13 kDa subunit 1; V-ATPase subunit G 1; vacuolar ATP synthase subunit M16; vacuolar H(+)-ATPase subunit G 1; vacuolar proton pump subunit G 1; vacuolar proton pump subunit M16
Santa Cruz Biotechnology
mouse monoclonal (D-5) |
| In order to identify the protein ATM as a target for senescence alleviation through chemical screen, Santa Cruz Biotechnology ATP6V1G1 antibody (Santa Cruz, sc-25333) was used in immunoprecipitation on human samples (fig 2b) and in western blot on human samples at 1:150 (fig 2b). Nat Chem Biol (2017) ncbi |
mouse monoclonal (D-5) |
| Santa Cruz Biotechnology ATP6V1G1 antibody (Santa Cruz, D-5) was used in immunocytochemistry on human samples (fig 1d), in immunohistochemistry on human samples (fig s4a) and in western blot on human samples (fig 3b). Oncotarget (2015) ncbi |
Articles Reviewed
- Di Cristofori A, Ferrero S, Bertolini I, Gaudioso G, Russo M, Berno V, et al. The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma. Oncotarget. 2015;6:17514-31 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments